• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主-肠道微生物群代谢相互作用。

Host-gut microbiota metabolic interactions.

机构信息

Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.

出版信息

Science. 2012 Jun 8;336(6086):1262-7. doi: 10.1126/science.1223813. Epub 2012 Jun 6.

DOI:10.1126/science.1223813
PMID:22674330
Abstract

The composition and activity of the gut microbiota codevelop with the host from birth and is subject to a complex interplay that depends on the host genome, nutrition, and life-style. The gut microbiota is involved in the regulation of multiple host metabolic pathways, giving rise to interactive host-microbiota metabolic, signaling, and immune-inflammatory axes that physiologically connect the gut, liver, muscle, and brain. A deeper understanding of these axes is a prerequisite for optimizing therapeutic strategies to manipulate the gut microbiota to combat disease and improve health.

摘要

肠道微生物组的组成和活性与宿主一起从出生开始发展,并受到复杂的相互作用的影响,这些相互作用取决于宿主的基因组、营养和生活方式。肠道微生物组参与调节多种宿主代谢途径,形成了相互作用的宿主-微生物代谢、信号和免疫炎症轴,这些轴在生理上连接着肠道、肝脏、肌肉和大脑。深入了解这些轴是优化治疗策略以操纵肠道微生物组来对抗疾病和改善健康的前提。

相似文献

1
Host-gut microbiota metabolic interactions.宿主-肠道微生物群代谢相互作用。
Science. 2012 Jun 8;336(6086):1262-7. doi: 10.1126/science.1223813. Epub 2012 Jun 6.
2
Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk.肠道微生物组成和活性与宿主代谢表型和疾病风险的关系。
Cell Metab. 2012 Nov 7;16(5):559-64. doi: 10.1016/j.cmet.2012.10.007.
3
The gut microbiota and the metabolic health of the host.肠道微生物组与宿主的代谢健康。
Curr Opin Gastroenterol. 2014 Mar;30(2):120-7. doi: 10.1097/MOG.0000000000000039.
4
[Gut microbiota and immune crosstalk in metabolic disease].[代谢性疾病中的肠道微生物群与免疫相互作用]
Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6.
5
Effects of the gut microbiota on obesity and glucose homeostasis.肠道微生物群对肥胖和葡萄糖稳态的影响。
Trends Endocrinol Metab. 2011 Apr;22(4):117-23. doi: 10.1016/j.tem.2011.01.002. Epub 2011 Feb 23.
6
Gut microbiota drives metabolic disease in immunologically altered mice.肠道微生物群驱动免疫改变小鼠的代谢性疾病。
Adv Immunol. 2012;116:93-112. doi: 10.1016/B978-0-12-394300-2.00003-X.
7
Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.肠-肝轴:肠道微生物群对非酒精性脂肪性肝病的影响。
Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):471-6. doi: 10.1016/j.numecd.2012.02.007. Epub 2012 Apr 28.
8
Gut microbiota, host health, and polysaccharides.肠道微生物群、宿主健康和多糖。
Biotechnol Adv. 2013 Mar-Apr;31(2):318-37. doi: 10.1016/j.biotechadv.2012.12.009. Epub 2012 Dec 30.
9
Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.肠道微生物群、肠道通透性、肥胖引起的炎症和肝损伤。
JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1.
10
Gut microbiota in health and disease: an overview focused on metabolic inflammation.健康与疾病中的肠道微生物群:聚焦代谢性炎症的概述
Benef Microbes. 2016;7(2):181-94. doi: 10.3920/bm2015.0062. Epub 2015 Dec 8.

引用本文的文献

1
Role of curcumin in altering gut microbiota for anti-obesity and anti-hyperlipidemic effects.姜黄素在改变肠道微生物群以产生抗肥胖和抗高血脂作用中的作用。
Front Microbiol. 2025 Aug 20;16:1625098. doi: 10.3389/fmicb.2025.1625098. eCollection 2025.
2
Gut microbiome communities demonstrate fine-scale spatial variation in a closed, island bird population.在一个封闭的岛屿鸟类种群中,肠道微生物群落呈现出精细尺度的空间变异。
ISME Commun. 2025 Aug 11;5(1):ycaf138. doi: 10.1093/ismeco/ycaf138. eCollection 2025 Jan.
3
Role of gut microbiota in the pathogenesis of metabolic syndrome: an updated comprehensive review from mechanisms to clinical implications.
肠道微生物群在代谢综合征发病机制中的作用:从机制到临床意义的最新综合综述
Ann Med Surg (Lond). 2025 Jul 29;87(9):5851-5861. doi: 10.1097/MS9.0000000000003656. eCollection 2025 Sep.
4
Deciphering the Potential Causal and Prognostic Relationships Between Gut Microbiota and Brain Tumors: Insights from Genetics Analysis and Machine Learning.解读肠道微生物群与脑肿瘤之间潜在的因果关系和预后关系:来自遗传学分析和机器学习的见解
Exploration (Beijing). 2025 May 1;5(4):e20240087. doi: 10.1002/EXP.20240087. eCollection 2025 Aug.
5
Establishment and development of the gut microbiota in dairy goats during the early life.奶山羊早期生命阶段肠道微生物群的建立与发育
BMC Vet Res. 2025 Aug 26;21(1):523. doi: 10.1186/s12917-025-04958-8.
6
Intestinal bacteria translocation promotes β-cell dysfunction in DIO mice.肠道细菌易位促进饮食诱导肥胖(DIO)小鼠的β细胞功能障碍。
Sci Rep. 2025 Aug 23;15(1):31034. doi: 10.1038/s41598-025-15244-w.
7
Gut microbial metabolite TMAO impairs cognitive function and induces hippocampal synaptic plasticity decline through modulation of GSK-3β activity.肠道微生物代谢产物氧化三甲胺通过调节糖原合成酶激酶-3β(GSK-3β)的活性损害认知功能并导致海马突触可塑性下降。
Alzheimers Res Ther. 2025 Aug 22;17(1):196. doi: 10.1186/s13195-025-01846-z.
8
Enrichment of short-chain fatty acid-producing bacteria by pH-responsive sodium alginate and chitosan-encapsulated quercetin.通过pH响应性海藻酸钠和壳聚糖包封的槲皮素富集产短链脂肪酸细菌。
Front Microbiol. 2025 Aug 6;16:1594012. doi: 10.3389/fmicb.2025.1594012. eCollection 2025.
9
Small intestinal bacterial overgrowth as one of the diagnostic markers of hypertension.小肠细菌过度生长作为高血压的诊断标志物之一。
Sci Rep. 2025 Aug 14;15(1):29785. doi: 10.1038/s41598-025-15536-1.
10
Mapping out the gut microbiota-dependent trimethylamine N-oxide super pathway for systems biology applications.绘制用于系统生物学应用的肠道微生物群依赖性三甲胺 N-氧化物超级途径。
Front Syst Biol. 2023 Mar 8;3:1074749. doi: 10.3389/fsysb.2023.1074749. eCollection 2023.